Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Publication|Articles|November 21, 2023
- November 2023
- Volume 89
- Issue 11
Pet Peeves: November 2023
Advertisement
Little Flexibility
When patients want to use their flex savings card for OTC products and want to pay at the pharmacy counter rather than paying up front.
Articles in this issue
almost 3 years ago
Pharmacist Spotlight: Joanna Lewis, PharmD, MBAalmost 3 years ago
Fun Facts: Are Antacids Just Chalk?almost 3 years ago
Prescription: Beyfortus From Sanofi Pasteur, Incalmost 3 years ago
Pharmacy Technician Roles Are Growing and Expandingalmost 3 years ago
Three Perspectives on Pharmacy Technician Retirementalmost 3 years ago
November 2023: Case Studiesalmost 3 years ago
Condition State Management: Substance Abusealmost 3 years ago
Failure to Contact Patient Leads to Severe Health Consequences, Lawsuitalmost 3 years ago
OTC Case Studies: Self-Care for Oral HealthNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive BP Control Cuts CV Risk Regardless of CKD Status
2
Pneumonic Plague: Symptoms, Antibiotics, and Current US Risk
3
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
4
Inside the New Consensus Recommendations for Acute Stroke Care
5